Sr. Scientific Director- Discovery Immunology Therapeutic Area Lead for Nonclinical Safety

Johnson & Johnson, is recruiting for a Sr.

Scientific Director- Discovery Immunology Therapeutic Area Lead for Nonclinical Safety to be located in La Jolla, CA.

At Johnson & Johnson,we believe health is everything.

Our strength in healthcare innovation empowers us to build aworld where complex diseases are prevented, treated, and cured,where treatments are smarter and less invasive, andsolutions are personal.

Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more at https://www.jnj.com/ .

For more than 130 years, diversity, equity & inclusion (DEI) has been a part of our cultural fabric at Johnson & Johnson and woven into how we do business every day.

Rooted in Our Credo, the values of DEI fuel our pursuit to create a healthier, more equitable world.

Our diverse workforce and culture of belonging accelerate innovation to solve the world's most pressing healthcare challenges.

We know that the success of our business - and our ability to deliver meaningful solutions - depends on how well we understand and meet the diverse needs of the communities we serve.

Which is why we foster a culture of inclusion and belonging where all perspectives, abilities and experiences are valued and our people can reach their potential.

At Johnson & Johnson, we all belong.

The early therapeutic area lead (eTAL) in nonclinical safety (NCS PSL) is a senior leadership role that primarily sits in the interface between PSTS and the therapeutic areas.

The NCS TAL may be a manager but is primarily seen as a scientific leader role with significant "matrix" management responsibility, serving as the coach and mentor for the NCS leads who work on the projects as assigned in the therapeutic area portfolio.

This role is assigned specifically to support the Immunology portfolio and has responsibility for projects that cover multiple modalities primarily from target selection to candidate nomination.

The eTAL has significant experience in drug development and regulatory sciences and has specialized knowledge and passion for the therapeutic area.

The eTAL faces TA leadership in TA forums and development stage gate forums, and, as needed to stand in as delegate for PSTS Global Head.

The eTAL is accountable for recommendations for diligence (including review and coaching of NCS diligence point person).

The primary role of the eTAL is to provide coaching and mentorship for NCS Leads working in their portfolio including mandatory advice and review of toxplans, protocols with the purpose of assuring scientific and regulatory questions are proactively addressed.

The eTAL is expected to maintain scientific depth and expert working knowledge of competitive intelligence and regulatory landscape in Immunology arena and to tracks milestones, issues, and attrition and should highlight strategic gaps...